chrisvoncsefalvay/vaers-outcomes huggingface dataset:
8-19-2016 4:26pm PC from grandma, client reports left upper very sore; can hardly move it with rash red et raise et one dollar in size; afebrile; reddened area to the front et outer aspect of left forearm well below injection site; s/s started one day before; advised to seek medical care; evaluated by Emergency on 8/19/2016 at 4:56pm; client prescribed ZYRTEC 10mg po daily for 3 days et to follow with primary physician.
less than 12 hours after vaccine, developed chills myalgias sweats fever. Lasted 3 am until 2 pm.  Examined 2 days later by MD no other source of symptoms
I developed muscle twitching in both legs beginning the day after injection.  It has remained consistent for a month now.  Additionally, I may experience muscle twitching in my arms, eye, back, or abdomen.
Left side of my face went numb. 5 minutes later tongue was dry and tingly. Went back to place of work and went to monitoring room. Went to ER to be checked out. Got better over that day.  I was admitted the same day and discharged the next day.
While walking a patient from urgent care to radiology at approximately 1632 on 4/12/21, I witnessed another patient (patient affected by event) fall to the floor by the pharmacy window. I rushed to the patient's side and began an initial assessment of airway, breathing, and circulation. No active bleeding or head injury detected. The patient was lying to her right side and appeared to be unconscious. No response when called or tapped on the shoulder several times. Patient's eyes appeared to be half-open without apparent movement. I asked for assitance from nearby security officer to call an ERT. Approximately 30-45 seconds into event, patient's daughter appeared on scene and attempted to call patient without response. While daughter assisted with supporting the patient's head, the patient suddenly took a deep breath and appeared to blink eyes several times (approx 5 seconds) before returning to previous unconscious state. No response when called by daughter throughout event. Another staff member appeared on scene at this time and recorded the second unconsciousness episode, which lasted for 90 seconds. ERT, urgent care providers, and other staff members were on scene at this time. 911 called. Vital signs taken and further assessments conducted. A pillow was placed under the patient's head and cervical collar applied. Patient appeared to be confused and in and out of consciousness at this moment. Patient was not able to identify name, date of birth, or current location but did state she had pain in her neck when asked in Spanish by another urgent care staff member. 911 staff on site at approximately 1645. Patient left in stable condition via ambulance gurney to higher level of care, accompanied by daugher and  paramedics.
Immediately after receiving the vaccine, I felt extremely weak and dizzy. The next three days I had a lot of pain at the injection site. It has been over a month and I still get very dizzy to the point where I am not able to stand up straight. I lose balance. Approximately two weeks after the vaccine, I started having problems with my left eye. It twitches about once every hour. This was not a problem I had before the vaccine.
Patient received vaccines on 6/8/07.  Patient returned to clinic for a viral illness as well as complaints of redness to left leg.  Patient was instructed to apply warm compresses to area and administer Tylenol PRN.  Patient was also instructed to return to clinic for signs and syptoms of infection.
Sudden onset tachycardia, diaphoresis, near syncope, extreme muscle weakness, extreme fatigue, low grade fever, elevated BP; paramedics evaluated. Sx improved without intervention.
Patient received PREVNAR (PCV13) on 9/2, she subsequently developed initial onset of fever (oral 102 at home), night sweats. Then a rash began on her hands as pinpoint ulcerations, followed by superficial peeling of the epidermis which spread to entire body sparing face, neck, mucous membranes. Associated with loss of appetite and increase sensation of thirst. She was given an Rx for prednisone 20mg x 5 days.
2hrs after vaccination, begun feeling right arm pain (on vaccine site), headache mild but continued until 4 pm same day, dizziness, felt cold though heavily dressed, right cheek tingling. Visited ED was evaluated however found to be hypertensive 170/95 (no prior history) later improved some mild headache, pain right arm improved e discharged when pain became g pain and dizziness mild , no more sensation of being cold, and assured by ED doc symptoms will improve x24 hrs. If worsen contact primary care physician
Sore injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore injection site pain) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included AMLODIPINE BESILATE (AMLODIPINE BESYLATE), PROGESTERONE and ESTRADIOL for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, the patient experienced VACCINATION SITE PAIN (Sore injection site pain). At the time of the report, VACCINATION SITE PAIN (Sore injection site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication provided by reporter.   This case was linked to MOD-2021-239156.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 50-year-old male patient received BNT162b2 (BNT162B2), on 19Mar2021 as dose 1, single (Batch/Lot number: unknown), in right arm, on 09Apr2021 as dose 2, single (Batch/Lot number: unknown), in right arm and on 11Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 50 years, in right arm for Covid-19 immunisation; CoviD-19 vaccine miRNA (miRNA 1273) (MODERNA COVID-19 VACCINE), on 11Mar2022 at 17:30 as dose 4 (booster), single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history included: "COVID-19" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 15May2022 at 21:00, outcome "recovering" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative; Positive. The action taken for CoviD-19 vaccine miRNA (miRNA 1273) was unknown. Therapeutic measures were taken as a result of drug ineffective, Covid-19. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Took Tylenol on Monday night due to stomach upset, felt like she had chills and had fever which was 97.  Woke up this morning with her stomach being upset again at 3:00 AM.  Still having excessive bowel movements.   Back of her neck hurts as well.  Stomach feels okay while she's sitting down, but once she stands up it feels like she has to go to the bathroom again.
hasn't received second shot (>42 days following first dose); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (hasn't received second shot (>42 days following first dose)) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (hasn't received second shot (>42 days following first dose)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (hasn't received second shot (>42 days following first dose)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  Treatment medication was not provided.
Pt had swollen lymph nodes under left armpit x 3 days pt called MD and was told to take ibuprofen: Symptoms resolved w/in 24 hours of taking MOTRIN.
This spontaneous report as received from a health care worker who reported that on an unspecified date, an unknown number of doses of PNEUMOVAX23 (lot number, dose and route not reported) were improperly stored at 10 degrees C., that may have been administered. No adverse effect was reported. Additional information has been requested.
vaccination site erythema; This spontaneous case was reported by a health care professional and describes the occurrence of ERYTHEMA (arm got red again) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 13-Jan-2021, the patient experienced ERYTHEMA (arm got red again). At the time of the report, ERYTHEMA (arm got red again) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information and concomitant medications provided.
Symptoms started at 6 am the morning after vaccination. Back, hip, and knee pain with increasing fatigue. As the morning progressed her skin started to hurt and spiked a fever with chills. She left work early due to the increasing severity of symptoms. At around 5 pm on the night after the vaccine, she was nauseous and the pain became severe enough she was having trouble drawing in a deep breath. She developed a sore throat and severe chills shortly after and she went to bed. In the middle of the night she woke up in a sweat like her fever had broken. On 08/16/2019 she felt better with mild soreness in her back and her skin, a slight headache, and a few hot flashes but no chills. The first injection was given on 06/05/2019 with only muscle soreness at the injection site for two to three days. The second dose was given on 08/14/2019 just past the two month mark.
Itching and redness around and below the injection site also slight swelling in same area. No treatment. Still occurring. Started 9 days after injection. Also not sure if related to vaccine but get slightly winded in daily activities. Started a day after vaccine and still occurring. No treatment
Slurred speech; This is a spontaneous report from a contactable consumer (patient). A 49-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6205), dose 2 via an unspecified route of administration, administered in Arm Left on 08Mar2021 12:30 as SINGLE DOSE for covid-19 immunisation. The patient medical history included autoimmune thyroiditis from an unknown date and unknown if ongoing, polycystic ovaries from an unknown date and unknown if ongoing, dairy intolerance (allergy to dairy) from an unknown date and unknown if ongoing, drug hypersensitivity (hydrocodone and Darviset allergy) from an unknown date and unknown if ongoing. The patient's concomitant medications included levotyroxine (levothyroxine), liothionine (liothyronine) and estrogen patch (estrogen). The patient's historical vaccine included the first dose of PFIZER-BIONTECH COVID-19 VACCINE on 15Feb2021 at 12:45PM on right arm. The patient had not taken any other vaccine in four weeks prior to the first dose of COVID-19 vaccine. The patient did not have COVID prior to COVID vaccination. On 08Mar2021 at 07:00 PM, the patient experienced slurred speech. The patient was not tested for COVID post vaccination. The patient did not receive treatment for the event. The outcome of the event was recovered on an unspecified date 2021.  No follow-up attempts are possible.
Patient is a 61 y.o. female with history of Lung adenocarcinoma with brain metastasis, COPD, Hepatitis C, Arthritis, polysubstance abuse, Tobacco abuse, and Anxiety who presented to a local Medical Center with declining mental status and worsening brain metastasis and found to also have covid-19 infection and was subsequently intubated.   Acute respiratory failure, resolved Intubated (4/9) due to AMS from brain mets and covid/PNA Extubated (4/11) Weaned to room air (4/13) Pulm followed   Acute encephalopathy Likely due to worsening brain mets with vasogenic edema Continue decadron and keppra Oriented x 2-3 (4/13)   Stage IV lung adenocarcinoma Brain metastasis Biopsy 1/10/2023 with adenocarcinoma Patient was receiving brain radiation but noncompliant CT Head (4/9) with multiple cerebral metastasis with significant vasogenic edema  On decadron and keppra Neurosurgery, oncology and palliative care consulted Rad/onc consulted; possibly resume radiation outpt if improves but no benefit for inpt, continue steroids Neurosurgery discussing surgical intervention vs palliative care with family Family and pt wish for hospice and dc home Plan to discharge home   Severe sepsis Covid -19 infection Bacterial pneumonia CT chest with LUL consolidation and b/l GGO Covid positive 4/9, unknown vaccination status Urinary antigen positive for pneumococcal Continue Azithro, rocephin changed to omnicef Continue decadron  Remdesivir stopped due to AKI   Hyperglycemia A1c 5.6 Likely due to steroids SSI   COPD Not in acute exacerbation Continue symbicort and bronchodilators
Terrified; It has been more than 42 days since his received his first dose.; This spontaneous case was reported by a consumer and describes the occurrence of FEAR (Terrified) and PRODUCT DOSE OMISSION ISSUE (It has been more than 42 days since his received his first dose.) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included APIXABAN (ELIQUIS) and METFORMIN for an unknown indication.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced FEAR (Terrified) and PRODUCT DOSE OMISSION ISSUE (It has been more than 42 days since his received his first dose.). At the time of the report, FEAR (Terrified) and PRODUCT DOSE OMISSION ISSUE (It has been more than 42 days since his received his first dose.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Contact information and Date of birth updated
pt diagnosed with right transverse sinus thrombosis, non-occlusive diagnosed 2d later.  also had pre-eclampsia.
This spontaneous report was received from a 68-year-old male patient who was referring to himself. The patient's medical history included back surgery. His concurrent conditions included reaction/allergy to codeine. He had no concomitant medications. On 06-DEC-2013, the patient was vaccinated with PNEUMOVAX23 (dose, site and route of administration, lot number and expiration date were not reported) as routine vaccination. On 09-DEC-2013, reported as 3 days after the vaccination, he experienced myelitis transverse described as "falling on his face". On an unknown date, the patient sought medical attention by going to an emergency room and he was hospitalized. He had a spinal taps performed (no results were provided) and an unspecified treatment was administered. He needed a wheelchair in 2014. The outcome of the event and the causality between the event and PNEUMOVAX23 were not reported. Upon internal review, the event of myelitis transverse was determined to be medically significant and disabling.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 23Sep2022 as dose 5 (booster), single (Lot number: GH9702) at the age of 68 years, in right arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 11Feb2021 as dose 1, single (Lot number: en6201), in left arm, on 04Mar2021 as dose 2, single (Lot number: en6206), in left arm, on 24Sep2021 as dose 3 (booster), single (Lot number: ff2587), in left arm and on 22Apr2022 as dose 4 (booster), single (Lot number: fj6369), in left arm for covid-19 immunisation. The patient's relevant medical history included: "crohns disease" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: MESALAMINE; LIOTHYRONINE; LEVOTHYROXINE. Past drug history included: Barium sulfate, reaction(s): "Known Allergies: Barium sulfate".  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 03Jan2023, outcome "not recovered" and all described as "COVID-19". Therapeutic measures were not taken as a result of vaccination failure, covid-19.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300005868 Same patient, different product and event;
Woke up following morning with soreness in arm, chills, and bad headache as well as congestion. Standing for more than a couple of minutes caused lightheaded feeling.   A high fever started around 5 pm that night and lasted until midnight when it seemed to break while I was sleeping after taking Tylenol.  The next day mild headache remained but was much better overall other symptoms did not remain.
Pt received 2 doses of varicella vaccine- 1/23/2012 and 8/11/2016 (Proquad- L032761) and was then diagnosed with chickenpox on 11/1/2022
Began with tickle in throat; increased to squeezing sensation in throat. Harsh barking cough, wheezing, chest tightness.
patient given pfizer booster, later found to have had moderna series on 04/07/21, 05/05/21, and 11/07/21, in addition to pfizer series on 03/07/21 and 03/28/21.
PT had a flu shot on 11/4/02. That evening, she developed hives on torso and both arms, next day both legs with intense itching. Hives and itching lasted 3 days then subsided. 12/13/02 PT used Aveno lotion - did not go to MD or take antihistamines. Now says hives occurred 48-50 hrs later on 11/6/02. Says this was flu 12 #2.
it is like multiple sclerosis presentation; lower extremities weakness; he is undergoing plasmapheresis to try to restore his neurological functions; This is a spontaneous report from a contactable physician. A 41-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 at the age of 41-years-old via an unspecified route of administration on 25May2021 (Batch/Lot Number: EW0182) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included anxiety from an unknown date. Concomitant medications included escitalopram oxalate (LEXAPRO) and escitalopram (ESCITALOPRAM) taken for anxiety, start and stop date were not reported. The patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) at the age of 41-years-old on 04May2021 (Lot No: EW0173) for covid-19 immunisation. The physician reported that on an unspecified date in 2021 (reported as half a month ago; for further clarification), the patient came in with lower extremities weakness, he had MRI, which shows abnormalities, may be suggestive of multiple sclerosis and enhancing bilateral wide regions of brain, cervical and thoracic cords, suggesting multiple sclerosis or the other ideologies are possible. He had a final tap that was also abnormal. And he is undergoing plasmapheresis to try to restore his neurological functions. The patient was hospitalized due to the events on 22Jul2021. The outcome of the events was unknown.; Sender's Comments: The events most likely an intercurrent conditions and unrelated to suspect product  bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE). Case will be reassessed when additional information is received.
Redness, swelling start about 5 cm below injection site. Proceeds distally to approx 2 cm above elbow, nearly circumferential. Pain at injection site. Pt received PNEUMOVAX previously without any effects.
Several rashes on arms, all over back and stomach. Rashes are circular/oval diferente sizes flat and dry. They flare up at times only around the edge. Sometimes itchy.
pt devel sz,vomit, low grade fever, lethargy & lack of body control;sz became more frequent;pt hosp;MRI & culture nl;EEG slow; since 6/18/99 hosp x4;devel rash from meds used to treat lack of immunity; encephalopathy or encephalitis per MD  Per doc 198117, child no longer patient of this physician
developed a rash on her leg; difficulty breathing; fast heartbeat; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH (developed a rash on her leg), DYSPNOEA (difficulty breathing) and HEART RATE INCREASED (fast heartbeat) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced RASH (developed a rash on her leg), DYSPNOEA (difficulty breathing) and HEART RATE INCREASED (fast heartbeat). At the time of the report, RASH (developed a rash on her leg), DYSPNOEA (difficulty breathing) and HEART RATE INCREASED (fast heartbeat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Fatigue, muscle/body/joint pain, dizzy, chills & feverish symptoms lasting almost 10 days since 1st vaccine.
Arm pain: mild on day of vaccination, moderate next morning, then mild/gone 20+ hours post -vaccination; Moderate to mild myalgia; Moderate fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 46-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 24Sep2022 at 17:00 as dose 4 (booster), single (Lot number: GJ6739) intramuscular, in right arm for covid-19 immunization; influenza vaccine (INFLUENZA), on 24Sep2022 as dose 1, single (Batch/Lot number: unknown), in left arm. The patient's relevant medical history included: "Known allergies: lactose intolerance" (unspecified if ongoing), notes: Known allergies: lactose intolerance. The patient took concomitant medications. Past drug history included: Known allergies: acetaminophen allergy, reaction(s): "Drug allergy", notes: Known allergies: Acetaminophen allergy. Vaccination history included: Covid-19 vaccine (Dose: 03), for Covid-19 immunization; Covid-19 vaccine (dose 2), for Covid-19 immunization; Covid-19 vaccine (dose 1), for Covid-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 24Sep2022 at 22:00, outcome "not recovered", described as "Arm pain: mild on day of vaccination, moderate next morning, then mild/gone 20+ hours post -vaccination"; FATIGUE (non-serious) with onset 24Sep2022 at 22:00, outcome "not recovered", described as "Moderate fatigue"; MYALGIA (non-serious) with onset 24Sep2022 at 22:00, outcome "not recovered", described as "Moderate to mild myalgia". Therapeutic measures were not taken as a result of pain in extremity, myalgia, fatigue.  No follow-up attempts are possible. No further information is expected.
Painful/sore joints (shoulders and elbows) for two days. Almost went for treatment after about 48 hrs, but got through a rough night and the next morning it was gone.
Pt recvd vax 13OCT92 & on 17OCT92 10AM pt exp croup, SOB, chest tightness; family treated pt w/steam from shower until 5AM; sx were compatible w/virus;